These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Glucose-regulated protein 78 positivity as a predictor of poor survival in patients with renal cell carcinoma. Kuroda K; Horiguchi A; Asano T; Ito K; Asakuma J; Sato A; Yoshii H; Hayakawa M; Sumitomo M; Asano T Urol Int; 2011; 87(4):450-6. PubMed ID: 22076227 [TBL] [Abstract][Full Text] [Related]
9. Chromophobe renal cell carcinoma: the impact of tumor grade on outcome. Cheville JC; Lohse CM; Sukov WR; Thompson RH; Leibovich BC Am J Surg Pathol; 2012 Jun; 36(6):851-6. PubMed ID: 22367296 [TBL] [Abstract][Full Text] [Related]
13. Expression of hypoxia inducible factor-1α and 2α in conventional renal cell carcinoma with or without sarcomatoid differentiation. Ku JH; Park YH; Myung JK; Moon KC; Kwak C; Kim HH Urol Oncol; 2011; 29(6):731-7. PubMed ID: 19914104 [TBL] [Abstract][Full Text] [Related]
14. Identification of stanniocalcin 2 as prognostic marker in renal cell carcinoma. Meyer HA; Tölle A; Jung M; Fritzsche FR; Haendler B; Kristiansen I; Gaspert A; Johannsen M; Jung K; Kristiansen G Eur Urol; 2009 Mar; 55(3):669-78. PubMed ID: 18450365 [TBL] [Abstract][Full Text] [Related]
15. Alterations of global histone H3K9 and H3K27 methylation levels in bladder cancer. Ellinger J; Bachmann A; Göke F; Behbahani TE; Baumann C; Heukamp LC; Rogenhofer S; Müller SC Urol Int; 2014; 93(1):113-8. PubMed ID: 24556868 [TBL] [Abstract][Full Text] [Related]
16. Anillin expression is a marker of favourable prognosis in patients with renal cell carcinoma. Ronkainen H; Hirvikoski P; Kauppila S; Vaarala MH Oncol Rep; 2011 Jan; 25(1):129-33. PubMed ID: 21109967 [TBL] [Abstract][Full Text] [Related]
17. Histological subtyping and nuclear grading of renal cell carcinoma and their implications for survival: a retrospective nation-wide study of 629 patients. Gudbjartsson T; Hardarson S; Petursdottir V; Thoroddsen A; Magnusson J; Einarsson GV Eur Urol; 2005 Oct; 48(4):593-600. PubMed ID: 15964127 [TBL] [Abstract][Full Text] [Related]
18. Expression of epithelial-mesenchymal transition markers in renal cell carcinoma: impact on prognostic outcomes in patients undergoing radical nephrectomy. Harada K; Miyake H; Kusuda Y; Fujisawa M BJU Int; 2012 Dec; 110(11 Pt C):E1131-7. PubMed ID: 22712620 [TBL] [Abstract][Full Text] [Related]
19. Biologic significance of fascin expression in clear cell renal cell carcinoma: systematic analysis of primary and metastatic tumor tissues using a tissue microarray technique. Zigeuner R; Droschl N; Tauber V; Rehak P; Langner C Urology; 2006 Sep; 68(3):518-22. PubMed ID: 16979727 [TBL] [Abstract][Full Text] [Related]
20. Prognostic and diagnostic relevance of hypermethylated in cancer 1 (HIC1) CpG island methylation in renal cell carcinoma. Eggers H; Steffens S; Grosshennig A; Becker JU; Hennenlotter J; Stenzl A; Merseburger AS; Kuczyk MA; Serth J Int J Oncol; 2012 May; 40(5):1650-8. PubMed ID: 22327210 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]